(Q34481460)

2 August 2017

1 reference

title

Novel therapies for renal cell carcinoma. (English)

1 reference

2 August 2017

Fishman M

1

1 reference

2 August 2017

Seigne J

series ordinal

2

1 reference

2 August 2017

Antonia S

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1033-1044

1 reference

The Heidelberg classification of renal cell tumours.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Accumulation of HIF-1alpha under the influence of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Gene-modified dendritic cells for use in tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Influence of tumor size and surgical resection on cell-mediated immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Resection of metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1033

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/73193

Identifiers

DOI

10.1517/13543784.10.6.1033

1 reference

2 August 2017

1 reference